Zusammenfassung
Hintergrund und Ziel der Arbeit
Die „Descemet membrane endothelial keratoplasty“ (DMEK) erfreut sich seit ihrer Einführung vor über 10 Jahren weltweit zunehmender Beliebtheit in der Therapie der Fuchs-Dystrophie. Im vorliegenden Beitrag sollen am Zentrum für Augenheilkunde der Universität zu Köln gesammelte Erfahrungen der vergangenen Jahre in einer Übersicht dargestellt werden.
Methoden
Es erfolgte eine Literaturübersicht von Studien zur DMEK primär aus dem Zentrum für Augenheilkunde der Universität zu Köln. Es werden eigene Erfahrungen in den Bereichen der Spenderauswahl und Transplantatpräparation, der DMEK-Chirurgie, des Komplikationsmanagements und der postoperative Therapie zusammengefasst.
Ergebnis
Seit Einführung der DMEK haben Erfahrungszuwachs und fortwährende Verbesserungen von der Spender-Empfänger-Allokation bis hin zur postoperativen Nachsorge stattgefunden. Diese führen zur besseren Reproduzierbarkeit des Eingriffs für den Chirurgen, zum besseren postoperativen Ergebnis und zur Reduktion der Komplikationsrate am Patienten.
Diskussion
Die DMEK stellt ein sicheres und individualisiertes Verfahren zur Endotheltransplantation bei kornealer endothelialer Dysfunktion dar. Kontinuierliche Weiterentwicklungen des Verfahrens führen zu optimaleren Ergebnissen.
Abstract
Background and objective
Descemet membrane endothelial keratoplasty (DMEK) has increased in popularity since its introduction over 10 years ago. This article presents a summary of the experiences of the past years collected at the Department of Ophthalmology at the University of Cologne.
Methods
A literature review of DMEK studies primarily from the Department of Ophthalmology at the University of Cologne, Germany was carried out. Own experiences in the fields of donor selection and graft preparation, DMEK surgery, complication management and postoperative treatment are summarized.
Results
Since the introduction of DMEK experience has been gained and ongoing improvements have occurred ranging from donor-recipient allocation to postoperative follow-up. These led to a better reproducibility of the intervention for the surgeon, to a better postoperative result and to a reduction of the complication rate.
Discussion
The DMEK represents a safe and individualized procedure for endothelial transplantation for corneal endothelial dysfunction. Continuing development of the method leads to optimization and safer results.
Literatur
Bachmann B, Cursiefen C (2017) Intra- and postoperative complications and their management in DMEK (including re-DMEK). In: Cursiefen C, Jun AS (Hrsg) Current treatment options for Fuchs endothelial dystrophy. Springer, Cham, S 153–164
Bachmann B, Schrittenlocher S, Matthaei M et al (2019) DMEK in komplexen Augen. Ophthalmologe (im Druck)
Bachmann BO, Laaser K, Cursiefen C et al (2010) A method to confirm correct orientation of descemet membrane during descemet membrane endothelial keratoplasty. Am J Ophthalmol 149:922–925
Bachmann BO, Pogorelov P, Kruse FE et al (2008) Patientenzufriedenheit nach posteriorer lamellärer Keratoplastik (DSAEK). Klin Monatsbl Augenheilkd 225:577–581
Bachmann BO, Schrittenlocher SA, Schaub F et al (2017) DMEK: Probleme vermeiden, erkennen, lösen. Klin Monatsbl Augenheilkd 234:1354–1361
Baydoun L, Dapena I, Melles G (2016) Evolution of posterior lamellar keratoplasty: PK – DLEK – DSEK/DSAEK – DMEK – DMET. In: Cursiefen C, Jun AS (Hrsg) Current treatment options for Fuchs endothelial dystrophy. Springer, Cham, S 73–85
Bucher F, Hos D, Muller-Schwefe S et al (2015) Spontaneous long-term course of persistent peripheral graft detachments after descemet’s membrane endothelial keratoplasty. Br J Ophthalmol 99:768–772
Cursiefen C, Kruse FE (2010) DMEK: posteriore lamelläre Keratoplastiktechnik. Ophthalmologe 107:370–376
Cursiefen C, Steven P, Roters S et al (2013) Komplikationsvermeidung und -management bei „Descemet membrane endothelial keratoplasty“ (DMEK) und „Descemet stripping automated endothelial keratoplasty“ (DSAEK). Ophthalmologe 110:614–621
Flockerzi E, Maier P, Böhringer D et al (2018) Trends in corneal transplantation from 2001 to 2016 in Germany: a report of the DOG-section cornea and its keratoplasty registry. Am J Ophthalmol 188:91–98
Heindl LM, Koch KR, Bucher F et al (2013) Descemet membrane endothelial keratoplasty in eyes with glaucoma implants. Optom Vis Sci 90:e241–244 (discussion 1029)
Heindl LM, Riss S, Adler W et al (2013) Split cornea transplantation: relationship between storage time of split donor tissue and outcome. Ophthalmology 120:899–907
Heindl LM, Riss S, Bachmann BO et al (2011) Split cornea transplantation for 2 recipients: a new strategy to reduce corneal tissue cost and shortage. Ophthalmology 118:294–301
Heindl LM, Riss S, Laaser K et al (2011) Split cornea transplantation for 2 recipients—review of the first 100 consecutive patients. Am J Ophthalmol 152:523–532.e2
Heinzelmann S, Huther S, Bohringer D et al (2014) Influence of donor characteristics on descemet membrane endothelial keratoplasty. Cornea 33:644–648
Heinzelmann S, Maier P, Bohringer D et al (2015) Cystoid macular oedema following descemet membrane endothelial keratoplasty. Br J Ophthalmol 99:98–102
Hoerster R, Stanzel TP, Bachmann BO et al (2016) Intensified early postoperative topical steroids do not influence endothelial cell density after descemet membrane endothelial keratoplasty combined with cataract surgery (triple-DMEK). Cornea 35:1396–1400
Hoerster R, Stanzel TP, Bachmann BO et al (2016) Intensified topical steroids as prophylaxis for macular edema after posterior lamellar keratoplasty combined with cataract surgery. Am J Ophthalmol 163:174–179.e172
Hos D, Heindl LM, Bucher F et al (2014) Evidence of donor corneal endothelial cell migration from immune reactions occurring after descemet membrane endothelial keratoplasty. Cornea 33:331–334
Hos D, Tuac O, Schaub F et al (2017) Incidence and clinical course of immune reactions after descemet membrane endothelial keratoplasty: retrospective analysis of 1000 consecutive eyes. Ophthalmology 124:512–518
Iovieno A, Neri A, Soldani AM et al (2017) Descemetorhexis without graft placement for the treatment of Fuchs endothelial dystrophy: preliminary results and review of the literature. Cornea 36:637–641
Kinoshita S, Koizumi N, Ueno M et al (2018) Injection of cultured cells with a ROCK inhibitor for bullous keratopathy. N Engl J Med 378:995–1003
Kruse FE, Laaser K, Cursiefen C et al (2011) A stepwise approach to donor preparation and insertion increases safety and outcome of descemet membrane endothelial keratoplasty. Cornea 30:580–587
Kruse FE, Schrehardt US, Tourtas T (2014) Optimizing outcomes with Descemet’s membrane endothelial keratoplasty. Curr Opin Ophthalmol 25:325–334
Lang SJ, Bischoff M, Bohringer D et al (2014) Analysis of the changes in keratoplasty indications and preferred techniques. PLoS ONE 9:e112696
Lapp T, Heinzelmann S, Bohringer D et al (2018) Use of donor corneas from pseudophakic eyes for descemet membrane endothelial keratoplasty. Cornea 37:859–862
Maier AK, Gundlach E, Schroeter J et al (2015) Influence of the difficulty of graft unfolding and attachment on the outcome in descemet membrane endothelial keratoplasty. Graefes Arch Clin Exp Ophthalmol 253:895–900
Matthaei M, Bachmann B, Siebelmann S et al (2018) Technik der „Descemet membrane endothelial keratoplasty“ (DMEK): Videobeitrag. Ophthalmologe 115:778–784
Melles GRJ, Ong TS, Ververs B et al (2006) Descemet membrane endothelial keratoplasty (DMEK). Cornea 25:987–990
Price MO, Gupta P, Lass J et al (2017) EK (DLEK, DSEK, DMEK): new frontier in cornea surgery. Annu Rev Vis Sci 3:69–90
Price MO, Lisek M, Feng MT et al (2017) Effect of donor and recipient diabetes status on descemet membrane endothelial keratoplasty adherence and survival. Cornea 36:1184–1188
Price MO, Scanameo A, Feng MT et al (2016) Descemet’s membrane endothelial keratoplasty: risk of immunologic rejection episodes after discontinuing topical corticosteroids. Ophthalmology 123:1232–1236
Schaub F, Cursiefen C, Heindl LM (2015) Retrospective appraisal of split-cornea transplantation: an audit of 1141 donor corneas. JAMA Ophthalmol 133:1086–1087
Schaub F, Enders P, Bluhm C et al (2017) Two-year course of corneal densitometry after Descemet membrane endothelial keratoplasty. Am J Ophthalmol 175:60–67
Schaub F, Enders P, Snijders K et al (2017) One-year outcome after descemet membrane endothelial keratoplasty (DMEK) comparing sulfur hexafluoride (SF6) 20 % versus 100 % air for anterior chamber tamponade. Br J Ophthalmol 101:902–908
Schaub F, Enders P, Zachewicz J et al (2016) Impact of donor age on descemet membrane endothelial keratoplasty outcome: evaluation of donors aged 17–55 years. Am J Ophthalmol 170:119–127
Schaub F, Pohl L, Enders P et al (2017) Impact of corneal donor lens status on two-year course and outcome of Descemet membrane endothelial keratoplasty (DMEK). Graefes Arch Clin Exp Ophthalmol 255:2407–2414
Schaub F, Simons HG, Roters S et al (2016) Einfluss von 20 % Schwefelhexafluorid (SF6) auf humane korneale Endothelzellen: eine In-vitro-Studie. Ophthalmologe 113:52–57
Schrittenlocher S, Penier M, Schaub F et al (2017) Intraocular lens calcifications after (triple‑)descemet membrane endothelial keratoplasty. Am J Ophthalmol 179:129–136
Schrittenlocher S, Schaub F, Hos D et al (2018) Evolution of consecutive descemet membrane endothelial keratoplasty outcomes throughout a 5-Year period performed by two experienced surgeons. Am J Ophthalmol 190:171–178
Siebelmann S, Bachmann B, Lappas A et al (2016) Intraoperative optische Koharenztomographie bei hornhaut- und glaukomchirurgischen Eingriffen. Ophthalmologe 113:646–650
Siebelmann S, Gehlsen U, Le Blanc C et al (2016) Detection of graft detachments immediately following descemet membrane endothelial keratoplasty (DMEK) comparing time domain and spectral domain OCT. Graefes Arch Clin Exp Ophthalmol 254:2431–2437
Siebelmann S, Lopez Ramos S, Scholz P et al (2018) Graft detachment pattern after descemet membrane endothelial keratoplasty comparing air versus 20 % SF6 tamponade. Cornea 37:834–839
Siebelmann S, Matthaei M, Horster R et al (2017) Lutein and Brilliant Blue-based dye for donor preparation and transplantation in descemet membrane endothelial keratoplasty. Cornea 36:440–444
Siebelmann S, Ramos SL, Matthaei M et al (2018) Factors associated with early graft detachment in primary descemet membrane endothelial keratoplasty. Am J Ophthalmol 192:249–250
Siebelmann S, Scholz P, Sonnenschein S et al (2017) Anterior segment optical coherence tomography for the diagnosis of corneal dystrophies according to the IC3D classification. Surv Ophthalmol 63:365–380
Siggel R, Heindl LM, Cursiefen C (2015) Descemet membrane endothelial keratoplasty (DMEK) in phakic eyes with shallow anterior chamber. Graefes Arch Clin Exp Ophthalmol 253:817–819
Stanzel TP, Ersoy L, Sansanayudh W et al (2016) Immediate postoperative intraocular pressure changes after anterior chamber air fill in descemet membrane endothelial keratoplasty. Cornea 35:14–19
Steven P, Hos D, Heindl LM et al (2013) Immunreaktionen nach DMEK, DSAEK und DALK. Klin Monatsbl Augenheilkd 230:494–499
Steven P, Le Blanc C, Velten K et al (2013) Optimizing descemet membrane endothelial keratoplasty using intraoperative optical coherence tomography. JAMA Ophthalmol 131:1135–1142
Tourtas T, Heindl LM, Kopsachilis N et al (2013) Use of accidentally torn descemet membrane to successfully complete descemet membrane endothelial keratoplasty. Cornea 32:1418–1422
Tourtas T, Schlomberg J, Wessel JM et al (2014) Graft adhesion in descemet membrane endothelial keratoplasty dependent on size of removal of host’s Descemet membrane. JAMA Ophthalmol 132:155–161
Weller JM, Schlotzer-Schrehardt U, Tourtas T et al (2016) Influence of ultrastructural corneal graft abnormalities on the outcome of descemet membrane endothelial keratoplasty. Am J Ophthalmol 169:58–67
Danksagung
Wir danken den Mitarbeitern der Hornhautbank am Zentrum für Augenheilkunde der Uniklinik zu Köln für die Bereitstellung der Daten für Abb. 1.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
M. Matthaei, S. Schrittenlocher, D. Hos, S. Siebelmann, F. Bucher, F. Schaub, R. Hoerster, R. Siggel, S. Roters, L.M. Heindl, B. Bachmann und C. Cursiefen geben an, dass kein Interessenkonflikt besteht.
Dieser Beitrag beinhaltet keine von den Autoren durchgeführten Studien an Menschen oder Tieren.
Rights and permissions
About this article
Cite this article
Matthaei, M., Schrittenlocher, S., Hos, D. et al. Zehn Jahre „Descemet membrane endothelial keratoplasty“ bei Fuchs-Dystrophie. Ophthalmologe 116, 236–242 (2019). https://doi.org/10.1007/s00347-018-0800-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00347-018-0800-3